These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6688270)

  • 1. FDA industry relations, a fresh approach.
    Byers TE
    J Parenter Sci Technol; 1983; 37(3):105-6. PubMed ID: 6688270
    [No Abstract]   [Full Text] [Related]  

  • 2. Parenteral Drug Association response to the FDA compliance policy guide, #7132a.13, entitled, "Parametric release--terminally heat sterilized drug products".
    J Parenter Sci Technol; 1988; 42(4):105. PubMed ID: 3183862
    [No Abstract]   [Full Text] [Related]  

  • 3. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA and notices of observations (FDA forms 483).
    Loftus BT
    J Parenter Drug Assoc; 1978; 32(5):209-15. PubMed ID: 251197
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical GMPs.
    Bobrowicz G
    Qual Assur; 1994 Jun; 3(2):138-48. PubMed ID: 7804629
    [No Abstract]   [Full Text] [Related]  

  • 6. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strengthening drug manufacturing practices.
    Hecht A
    FDA Consum; 1976; 10(6):12-4. PubMed ID: 829227
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA audit of nonclinical studies.
    Horowitz AM
    Qual Assur; 1995 Sep; 4(3):227-38. PubMed ID: 8705117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on the U.S. FDA Bioresearch Monitoring Program.
    Gamet JE
    Qual Assur; 1995 Mar; 4(1):12-9. PubMed ID: 8520859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impending FDA regulations of healthcare software. First stop: blood banking. Interview by Bill W. Childs.
    Marrazzo J
    US Healthc; 1988 Nov; 5(11):17-8. PubMed ID: 10291018
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of total quality principles to achieve regulatory compliance in research laboratories.
    Hynes MD
    Qual Assur; 1995 Mar; 4(1):34-40. PubMed ID: 8520863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical product integrity: can the FDA assure quality?
    Bernstein I
    Manag Care; 2004 Mar; 13(3 Suppl):30-3. PubMed ID: 15074168
    [No Abstract]   [Full Text] [Related]  

  • 13. Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Dec; 72(232):68064-70. PubMed ID: 18064770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation of biopharmaceuticals.
    Weisbroth N
    Qual Assur; 1993; 2(1-2):147-51. PubMed ID: 8156202
    [No Abstract]   [Full Text] [Related]  

  • 15. Protecting the consumer from getting burned: the FDA, the administrative process, and the tentative final monograph on over-the-counter sunscreens.
    Jones PR
    Am J Law Med; 1994; 20(3):317-35. PubMed ID: 7702077
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA state of affairs.
    Lepore P
    Qual Assur; 1993; 2(1-2):156-61. PubMed ID: 8156204
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA pharmaceutical quality oversight.
    Yu LX; Woodcock J
    Int J Pharm; 2015 Aug; 491(1-2):2-7. PubMed ID: 26027494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA, OSHA, and EPA regulation of the recombinant DNA technology.
    Korwek EL
    J Parenter Sci Technol; 1982; 36(6):251-5. PubMed ID: 7161657
    [No Abstract]   [Full Text] [Related]  

  • 19. GMP criteria for retest and failure analysis. Handling out-of-specification results in the pharmaceutical quality control laboratory.
    Klein AE; Rocci ML
    Qual Assur; 1995 Dec; 4(4):247-51. PubMed ID: 8890350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving drug manufacturing with process analytical technology.
    Rodrigues LO; Alves TP; Cardoso JP; Menezes JC
    IDrugs; 2006 Jan; 9(1):44-8. PubMed ID: 16374733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.